Cadila pharmaceuticals launches Tikacad® an antiplatelet drug containing Ticagrelor, a P2Y12 platelet inhibitor indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients. Ahmedabad: Cadila Pharmaceuticals
Read More
Click Here
